Delivery Order SPE2DB22D1106-SPE2DB25FEKF9
Award Date
4/23/25
Potential Completion Date
4/24/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,067.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,930,393 units of the diabetes medication Jardiance 10 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 17, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $20,824.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of 4,567,943,078 units of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,931.70, is for the delivery of 4,567,874,185 units of the diabetes medication Jardiance 10 mg tablets. The award has an ultimate completion date of April 11, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,847.96 firm fixed-price delivery order is for the supply of 90 tablets of the diabetes medication JARDIANCE 10 MG. The contract has an ultimate completion date of May 13, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $15,633.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 24, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug...
This federal contract award, valued at $13,241.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a diabetes medication, with a performance period extending to April 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, valued at $4,167.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medication Jardiance 10 mg tablet, a diabetes treatment. It is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,638.40 firm fixed-price delivery order is for the supply of Jardiance 10 mg tablets, a diabetes medication. The contract has a completion date of June 9, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,434.44 firm fixed-price delivery order is for the provision of 90 count tablets of the diabetes medication Jardiance 25 mg. The contract has an ultimate completion date of June 27, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,176.95, is for the delivery of 4,568,106,779 units of the diabetes medication Jardiance 25 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 2, 2025. This award is not associated with a set-aside program and was competitively awarded....